Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-23-000138

Director sold 1,666 shares at an average $23.62 ($39,348)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
SATO VICKI L Director 2023-09-15 Sale 10b5-1 −1,626 $23.60 $38,374 129,745 D: show line 1 in the form
SATO VICKI L Director 2023-09-15 Sale 10b5-1 −40 $24.35 $974 129,705 D: show line 2 in the form
Open-market sales · 1,666 sh · avg $23.62 · $39,348
Loading xslF345X05/wk-form4_1695156311.xml…